Of 49 patients in whom telaprevir-resistant variants were detected by PS at the time of treatment failure but not at the end of the study , DS revealed the presence of variants ( V36A/L/M , T54S , or R155K in 1 % -36 % of the viral population ) in 16 patients ( 33 % ) at the end of the study .